tm
Seeing Is Believing
tm
Seeing Is Believing
Currently, out of the existing stock ratings of Liav Abraham - 91 which are a Buy (71.65%), 34 which are a Hold (26.77%), 2 which are a Sell (1.57%)
Analyst Liav Abraham works at CREDIT SUISSE and is covering the Healthcare sector with 248 price targets and ratings displayed on 12 stocks. Previously, Liav Abraham worked at CITI.
Liav Abraham's average stock forecast success ratio is 62.01% with an average time for price targets to be met of 303.42 days.
Most recent stock forecast was given on ELAN, Elanco Animal Health at 05-Aug-2021.
Analyst best performing recommendations are on INSM (INSMED).
The best stock recommendation documented was for ENDP (ENDO INTERNATIONAL PLC) at 6/27/2018. The price target of $11 was fulfilled within 12 days with a profit of $1.89 (20.75%) receiving and performance score of 17.29.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
193
$-0.02 (-0.01%)
178
3 years 5 months ago
4/11 (36.36%)
$28.2 (13.43%)
217
Buy
203
3 years 7 months 3 days ago
1/2 (50%)
$20.22 (11.61%)
95
Hold
198
$4.98 (2.58%)
189
3 years 7 months 30 days ago
3/10 (30%)
$56.89 (33.89%)
223
Hold
247
4 years 1 months 14 days ago
0/7 (0%)
$61.21 (30.90%)
Hold
165
$-28.02 (-14.52%)
125
4 years 1 months 14 days ago
5/5 (100%)
$3.03 (2.09%)
95
What Year was the first public recommendation made by Liav Abraham?
